Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1999-04-19
2000-07-04
Geist, Gary
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 56, 536 21, 536118, 424 92, A61K 31715, A61K 31725
Patent
active
060839333
ABSTRACT:
Cystitis of the bladder and urinary tract, particularly interstitial cystitis, are treated using effective unit doses of chondroitin sulfate. Further, cystitis patients are screened for their response to a given cystitis treatment using a method in which patients are first challenged with an irritant and then treated with a selected cystitis therapeutic. Candidates for further treatment are identified as those patients who on receiving the selected therapeutic, report relief from at least one symptom elicited with the irritant. Also provided are kits comprising solutions for carrying out this screening method.
REFERENCES:
patent: 5753266 (1998-05-01), Youssefyeh et al.
patent: 5880108 (1999-03-01), Morales et al.
Hurst et al, J. Urol., 138:433-437, 1987: (Aug., 1987). "Functional and Structural Characteristics of the Glycosaminoglycans of the Bladder Luminal Lining".
Conte et al, Arzneim-Forsch./Drug Res. 41(II), 7, 768-772 (1991) "Metabolic Fate of Exogenous Chondroitin Sulfate in Man".
Sant & LaRock, "Standard Intravesical Therapies for Interstitial Cystitis", in Urologic Clinics of North America, vol. 21, No. 1, Feb. 1994, at pp. 73-83.
Hurst et al, Urology 48:817-821, 1996 "A Deficit of Chondroitin Sulfate Proteoglycans on the Bladder Uroepithelium in Interstitial Cystitis".
Parsons et al, J. Urol., 159:1862-1867, 1998 (Jun., 1998). "The Role of Urinary Potassium in the Pathogenesis and Diagnosis of Interstitial Cystitis".
Schick, Canadian Journal of CME, Aug. 1998, pp. 55-66 "Interstitial Cystitis: Diagnosis and Treatment".
Internet Web Site www.ichelp.com accessed Jan. 15, 1999, Mast cells may account for success of GAG layer treatments, by editor Norman Bauman.
Erickson et al., "Urinary Chondroitin Sulfates, Heparin Sulfate and Total Sulfated Glycosaminoglycans in Interstitial Cystitis," Journal of Urology, 157(1), 61-64 (Jan., 1997).
Berkow et al. (eds.), Merck Manual of Diagnosis and Therapy, 16th Edition, Merck & Co., Rahway, NJ, 1992, only title & text pp. 1713-1714, 1722 and 2082 supplied.
Crane L. E.
Gastle James E.
Geist Gary
Stellar International Inc.
LandOfFree
Treatment of cystitis-like symptoms with chondroitin sulfate fol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of cystitis-like symptoms with chondroitin sulfate fol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cystitis-like symptoms with chondroitin sulfate fol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1486725